METTL14‐mediated lncRNA‐FAS‐AS1 promotes osteoarthritis progression by up‐regulating ADAM8 DOI

Zhehua Zhang,

Honggang Mao,

Fang Li

et al.

International Journal of Rheumatic Diseases, Journal Year: 2024, Volume and Issue: 27(9)

Published: Sept. 1, 2024

Osteoarthritis (OA) is a prevalent degenerative disease. We explored the role and regulatory mechanisms of lncRNA-FAS-AS1 in OA progression.

Language: Английский

The role and mechanism of m6A methylation in diabetic nephropathy DOI
Lin-Jing Yan, Liang Guo

Life Sciences, Journal Year: 2025, Volume and Issue: 363, P. 123355 - 123355

Published: Jan. 6, 2025

Language: Английский

Citations

1

mTOR Signaling Promotes Rapid m6A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions DOI
Meng Meng, Zhaoyang Zhong, Liang Song

et al.

Cancer Immunology Research, Journal Year: 2024, Volume and Issue: 12(8), P. 1039 - 1057

Published: April 19, 2024

NK cells can be rapidly activated in response to cytokines during host defense against malignant or viral infection. However, it remains unclear what mechanisms precisely and regulate the expression of a large number genes involved activating cells. In this study, we discovered that NK-cell N6-methyladenosine (m6A) methylation levels were upregulated upon short-term activation repressed tumor microenvironment (TME). Deficiency methyltransferase-like 3 (METTL3) METTL14 moderately influenced homeostasis, while double-knockout METTL3/14 more significantly impacted maturation, antitumor immunity. This suggests cooperative role METTL3 regulating development effector functions. Using methylated RNA immunoprecipitation sequencing, demonstrated functions, such as Prf1 Gzmb, directly modified by m6A methylation. Furthermore, inhibiting mTOR complex 1 prevented from increasing when activated, could restored S-adenosylmethionine supplementation. Collectively, have unraveled crucial roles for rapid mRNA downstream 1-S-adenosylmethionine signal axis

Language: Английский

Citations

7

Recent advances of m6A methylation in skeletal system disease DOI Creative Commons

Jian‐Hui Liang,

Qian Yi,

Yang Liu

et al.

Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: Feb. 14, 2024

Abstract Skeletal system disease (SSD) is defined as a class of chronic disorders skeletal with poor prognosis and causes heavy economic burden. m6A, methylation at the N6 position adenosine in RNA, reversible dynamic modification posttranscriptional mRNA. Evidences suggest that m6A modifications play crucial role regulating biological processes all kinds diseases, such malignancy. Recently studies have revealed most abundant epigentic modification, involved progression SSD. However, function SSD not fully illustrated. Therefore, make clear relationship between pathogenesis might provide novel sights for prevention targeted treatment This article will summarize recent advances regulation SSD, including osteoporosis, osteosarcoma, rheumatoid arthritis osteoarthritis, discuss potential clinical value, research challenge future prospect

Language: Английский

Citations

5

METTL3 upregulates IRF5 to epigenetically regulate inflammation, apoptosis and ferroptosis of IL-1β-induced CHON-001 chondrocytes through CX43 DOI
Xiaoying Wang,

Qingyu Lei,

Wei Zuo

et al.

Journal of Orthopaedics, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0

Machine Learning Discoveries of METTL3-X Synergy in ETC-1922159 Treated Colorectal Cancer Cells DOI
Shriprakash Sinha

Published: Jan. 1, 2025

Language: Английский

Citations

0

Therapeutic targets in aging-related osteoarthritis: A focus on the extracellular matrix homeostasis DOI Creative Commons
Hao Wan, Ming‐Fu Chang, Di Shi

et al.

Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123487 - 123487

Published: Feb. 1, 2025

Language: Английский

Citations

0

Methyltransferase‐Like 3‐Mediated N6‐Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases DOI Creative Commons
Dongqiong Xiao, Deshuang Zhang, Yi Qu

et al.

Journal of Cellular and Molecular Medicine, Journal Year: 2025, Volume and Issue: 29(5)

Published: March 1, 2025

Osteoarthritis, osteoporosis, and osteosarcoma are prevalent osseous pathologies associated with the aberrant functionality of chondrocytes, osteoclasts, osteoblasts, respectively. These conditions frequently exhibit therapeutic resistance possess a high mortality risk, thus representing substantial health threats. To mitigate these concerns, it is imperative to investigate novel mechanistic insights. Methyltransferase-like 3 (METTL3) pivotal in disorders by modulating gene expression via N6-methyladenosine (m6A) modifications on RNA, thereby impacting cellular processes. Although considerable research has elucidated METTL3's involvement diseases, systematic review essential summarise findings evaluate significance. This endeavours aggregate examine contemporary studies elucidate role bone its clinical implications. We propose that METTL3 constitutes risk mediating m6A both mRNAs non-coding RNAs, suggesting may serve as critical diagnostic biomarker target. In conclusion, this provides an extensive analysis correlation osteoarthritis, osteosarcoma, offering valuable perspectives extant serving reference for researchers engaged basic translational studies.

Language: Английский

Citations

0

Regulation of Skeletogenic Pathways by m6A RNA Modification: A Comprehensive Review DOI Creative Commons
Ehsan Pashay Ahi

Calcified Tissue International, Journal Year: 2025, Volume and Issue: 116(1)

Published: April 3, 2025

Language: Английский

Citations

0

RNA methylation: A new perspective in osteoarthritis research DOI

Guihao Zheng,

Mengji Lu,

Yulong Ouyang

et al.

Gene, Journal Year: 2025, Volume and Issue: 959, P. 149518 - 149518

Published: April 18, 2025

Language: Английский

Citations

0

From bone marrow mesenchymal stem cells to diseases: the crucial role of m6A methylation in orthopedics DOI Creative Commons
Jing Li, Chu Zhang, Wen Yin

et al.

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 6, 2025

Elucidating the molecular mechanisms underlying orthopedic diseases is crucial for guiding therapeutic strategies and developing innovative interventions. N6-methyladenosine (m6A)-an epitranscriptomic modification-has emerged as a key regulator of cellular fate tissue homeostasis. Specifically, m6A plays pivotal role in several RNA biological processes such precursor splicing, 3'-end processing, nuclear export, translation, stability. Recent advancements indicate that methylation regulates stem cell proliferation osteogenic differentiation by modulating various signaling pathways. Extensive research has shown abnormalities contribute significantly to onset progression osteoporosis (OP), osteoarthritis (OA), rheumatoid arthritis (RA), bone tumors. This review aims summarize proteases involved their functions. The detailed which marrow mesenchymal cells (BMSCs) through direct indirect ways are also discussed, with focus on specific Finally, this analyzes roles modification development multiple diseases, offering comprehensive understanding pathophysiology these conditions proposing new directions targets treatment strategies.

Language: Английский

Citations

0